Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 22NIH 18OTHER 12INDUSTRY 4UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 1Esophageal Neoplasms 1

Interventions

Paclitaxel 6Radiotherapy 3Epirubicin 3Radiotherapy, Intensity-Modulated 2Radiation Dose Hypofractionation 2Radiation 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Capecitabine 2pegylated granulocyte colony-stimulating factor 1nabiximols 1aumolertinib 1Zoledronic Acid 1Vinorelbine 1Temozolomide 1TP protocol 1Standard of Care 1S 1 (combination) 1Platinum 1Pemetrexed 1Neoadjuvant Therapy 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Drug Therapy 1Decitabine 1Chemotherapy, Adjuvant 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × UNKNOWN × Platinum × Clear all
NCT03731442 2018-12-12

Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients

ChineseAMS

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Esophageal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡